Please login to the form below

Not currently logged in
Email:
Password:

Eli Lilly sales reps offered voluntary exit

US drugmaker Eli Lilly has offered buyouts to thousands of its US sales representatives

US drugmaker Eli Lilly has offered buyouts to thousands of its US sales representatives in the hope that several hundred will opt for voluntary redundancy ahead of a planned restructuring.

Approximately 4,000 sales employees in the US diabetes, neuroscience and osteoporosis units will be eligible for the programme, but buyouts are limited to a few hundred.

"We're trying to lower our headcount ahead of the restructuring and get us closer to the desired number" said company spokesman Edward Sagebiel.

Employees who accept the buyout will be offered the company's standard severance package plus an additional four months pay, Sagebiel said.

The new structure will feature smaller territories, each with one sales rep who has deep expertise in a treatment area. The plans are to be announced in November 2009 and will begin in January 2010.

Eli Lilly have acknowledged that the headcount reductions are a response to the challenging economic environment and the 2011 patent expiration of its top-selling Zyprexa (olanzapine) schizophrenia drug.

5th August 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics